COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn BHBH FPVFPV FLVFLV PVP-IPI REGNR2 LY-CoVLY RMDRMD
HCQ study #245 of 264
1/25 Early treatment study
Dabbous et al., Archives of Virology, doi:10.1007/s00705-021-04956-9 (Peer Reviewed)
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
Source   PDF   Share   Tweet
RCT with 44 favipiravir patients and 48 CQ patients, showing non-statistically significant lower mortality, ventilation, and hospitalization time with favipiravir.

Dabbous et al., 1/25/2021, peer-reviewed, 10 authors.
Details of all 264 studies    Meta analysis
Please send us corrections, updates, or comments.